What To Know
- MIM SureCalc MonteCarlo gives access to an advanced Monte Carlo algorithm powered by SciMoCa™ and next-generation plan second check capabilities to aid patient replanning decisions.
- “With the growth of advanced treatment delivery methods such as CyberKnife, there is a need to evolve quality assurance methods to adequately evaluate these complex plans.
MIM SureCalc MonteCarlo has been selected for implementation by Stanford Health Care to perform second check for Accuray CyberKnife plans. The news was reported today by MIM Software Inc.
MIM SureCalc MonteCarlo gives access to an advanced Monte Carlo algorithm powered by SciMoCa™ and next-generation plan second check capabilities to aid patient replanning decisions.
“We are excited to expand our long-standing relationship with Stanford Health Care,” said Andrew Nelson, Chief Executive Officer of MIM Software Inc. “With the growth of advanced treatment delivery methods such as CyberKnife, there is a need to evolve quality assurance methods to adequately evaluate these complex plans. MIM SureCalc MonteCarlo empowers patient-specific QA to meet these demands, fulfill task group recommendations, and drive an automated and efficient clinical workflow.”
Monte Carlo simulation-based validation prevents systematic discrepancies in dose calculation while reducing dependence on manual quality assurance. Institution-specific beam models derived from validated base data can be utilized in MIM SureCalc MonteCarlo for superior plan second check accuracy.